Litcius/Paper detail

Lactose-modified enzyme-sensitive branched polymers as a nanoscale liver cancer-targeting MRI contrast agent

Xiaoqin Zhang, Xiaoming Wang, Zhiqian Li, Jun Du, Xiao Xueyang, Dayi Pan, Hu Zhang, Xiaohe Tian, Qiyong Gong, Zhongwei Gu, Kui Luo

2022Nanoscale11 citationsDOI

Abstract

MRI results of major organs. Therefore, the branched macromolecule BLDCGd could have great potential as an efficacious and bio-safe nanoscale MRI contrast agent for clinical diagnosis of liver cancer.

Topics & Concepts

Asialoglycoprotein receptorMRI contrast agentChemistryIn vivoMolecular imagingSmall moleculeBiophysicsIn vitroDOTACancer cellTetrapeptideMacromoleculeBiochemistryHepatocyteCancerPeptideGadoliniumChelationBiologyOrganic chemistryBiotechnologyGeneticsNanoparticle-Based Drug DeliveryNanoplatforms for cancer theranosticsLanthanide and Transition Metal Complexes
Lactose-modified enzyme-sensitive branched polymers as a nanoscale liver cancer-targeting MRI contrast agent | Litcius